Skip to main content
. 2017 Aug 17;3(3):00016-2017. doi: 10.1183/23120541.00016-2017

FIGURE 3.

FIGURE 3

Trend of forced vital capacity (FVC) in the disease-modifying drug (DMD) subgroup by therapy administered. Within the DMD subgroup of chronic hypersensitivity pneumonitis patients who had previously received prednisone (PRED), administration of mycophenolate mofetil or azathioprine therapy significantly altered the slope of monthly FVC decline (−0.7% versus −0.2%, p=0.001). Data analysed using mixed regression model.